Mature B cell lymphomas Flashcards
CLL/SLL
- CD19/CD5/CD23
- Dim: CD20 and surface light chain
Richter syndrome (diffuse large cell)
most common NHL
2nd most
DLBCL
Follicular
most common leukemia of adults in western world
CLL
Follicular lymphoma
CD19/CD20/CD10 Bright surface light chain restricted bcl2+ (in GC where normally shut off) bcl6+ (indicates cells have passed through GC stage of maturation) t(14;18) IgH (14) and BCL2 (18) bcl2: anti-apoptotic
Mantle Cell lymphoma
CD19/CD20/CD5
Bright CD20 and surface light chain
often CD23 negative (found in CLL/SLL)
t(11;14)
cyclin D1 (11) with IgH (14)
Cyclin D1: promotes progression of cell cycle from G1 to S
Detection: FISH, PCR, immunohistochemistry
Lymphomatoid polyposis = GI involvement
Marginal zone lymphoma
polyclonal → oligoclonal → monoclonal theory : reactive T-cell dependent for growth/survival
acquisition of t(11;18) or t(1;14) : independent of extrinsic stimuli. No response to antibiotics
Bcl10
MALT1
Lymphoplasmacytic lymphoma (LPL)
secrete monoclonal IgM (>3gm/dL)
hyperviscosity syndrome: Waldenstorm macroglobulinemia
nvolves BM
+/- spleen, nodes
high viscosity causes: visual sx (blurried vision), cns sx, bleeding (interference with coag factors and platelets), autoimmune hemolytic anemia (cold agglutinins - IgM), cryoglobulinemia - precipitation of IgM at low temps (fingers/toes)
MYD88
HCL
older male splenomegaly pancytopenia BRAF mutation involves blood, BM, splenic red pulp
diffuse “fried eggs” in BM
round to reniform nuclei (kidney beaned nuclei) with moderate amnt of pale blue cytoplasm w/ “hairs”
reticulin fibrosis - “dry tap” of BM
splenic red pulp w/ obliteration of white pulp
CD19/CD20/surface light chain restriction
CD11c/CD25/CD103
different type of treatment from other NHL
purine analogs → long remission
BRAF inhibitors
Multiple myeloma
anemia → weakness, fatigue
decreased Ig → recurrent infection
hypercalcemia → polyuria, constipation, confusion
tumor load → bone pain, pathologic fractures
Bence jones protein → renal insufficiency
light chain deposition in organs → amyloidosis
One class will be elevated, rest will be decreased: IgG > IgA»_space;»> IgM, IgE, IgD
PB rouleux (inc Ig in serum → RBC adhesion) PB: excess Ig in serum → acidic, so takes up blue (basophilic) stain PB plasma cell leukemia = end stage
translocations with IgH deletions of 17p(TP53) rearrangements of MYC IL-6 - GF produced tumors also influence activation of osteoclasts and inhibition of osteoblasts (no repair of bone → inc serum calcium
most common cause of monoclonal gammopathy
MGUS
Plasmacytoma
Solitary bone/soft tissue clonal plasma cell mass w/ no evidence of BM or organ disease - spine, lung and oronasopharynx
local
can progress to myeloma
Diffuse large B-cell lymphoma
High grade heterogenous lack specific risk factor immunodeficient EBV MOST COMMON NHL
Rapidly enlarging - single nodal/extranodal mass
“B-type” symptoms
BM - minority of ptns - late in disease
mitotically active
nondescript
bcl6 mutation (3q27) - cell has been through GC maturation
bcl2 mutation - t(14;18), transformed follicular lymphoma
cMYC mutation/translocation
Double hit lymphoma - translocation of both bcl2 and myc - aggressive, poor prognosis
Burkitt Lymphoma
High grade - HIGHEST Extranodal 30% childhood NH Tumor lysis syndrome - uric acid, k+, calcium “starry sky” basophilic cytoplasm with vacuoles CNS sx highly mitotic
CD19/CD20/CD10
surface light chain restriction
bcl6
grows fast - glycolysis translocation involving c-MYC(8q24) t(8;14) t(2;8) t(8;22)
Burkitt Lymphoma
Endemic vs sporadic
endemic EBV: precedes neoplasm. Mandibular mass, abdominal viscera
sporadic: abdominal mass in ileocecum and peritoneum